The pharmacological use of ellagic acid-rich pomegranate fruit
- 24 May 2013
- journal article
- review article
- Published by Taylor & Francis in International Journal of Food Sciences and Nutrition
- Vol. 64 (7) , 907-913
Abstract
In recent years, the therapeutic use of non-drug substances such as herbal and medicinal foods is increasing progressively. Of these substances, Punica granatum L., which is an ancient and highly distinctive fruit, has been proposed for treatment of several different illnesses. Ellagic acid (EA) is one of those biological molecules found in pomegranate and may have therapeutic potential in many diseases. EA has been detected not only in pomegranate but also in a wide variety of fruits and nuts such as raspberries, strawberries, walnuts, grapes and black currants, and is becoming an increasingly popular dietary supplement over recent years. Similar to other ellagitannins (ETs), EA is quite stable under physiological conditions in the stomach. EA and ETs as active agents induce vasorelaxation, oxygen free radical scavenging, hypolipidemic, anti-inflammatory and anti-carcinogenic activities in various animal preparations call an attention to the need for designing adequate tests in humans to assess these potentially useful properties in diseased states.Keywords
This publication has 75 references indexed in Scilit:
- Pomegranate Protection against Cardiovascular DiseasesEvidence-Based Complementary and Alternative Medicine, 2012
- AtherosclerosisCurrent Opinion in Lipidology, 2012
- Evaluation of the Anti-inflammatory Effects of Ellagic AcidJournal of PeriAnesthesia Nursing, 2010
- Antidiabetic effect of Punica granatum flowers: Effect on hyperlipidemia, pancreatic cells lipid peroxidation and antioxidant enzymes in experimental diabetesFood and Chemical Toxicology, 2009
- Pomegranate Phenolics from the Peels, Arils, and Flowers Are Antiatherogenic: Studiesin Vivoin Atherosclerotic Apolipoprotein E-Deficient (E0) Mice andin Vitroin Cultured Macrophages and LipoproteinsJournal of Agricultural and Food Chemistry, 2008
- Analytical methods for assay of ellagic acid and its solubility studiesJournal of Pharmaceutical and Biomedical Analysis, 2006
- Anthocyanin‐ and hydrolyzable tannin‐rich pomegranate fruit extract modulates MAPK and NF‐κB pathways and inhibits skin tumorigenesis in CD‐1 miceInternational Journal of Cancer, 2004
- Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidationClinical Nutrition, 2004
- Taurine and ellagic acid: Two differently‐acting natural antioxidantsEnvironmental and Molecular Mutagenesis, 1995
- The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitroNutrition and Cancer, 1995